Do patients with an implantable defibrillator live longer?

Journal of the American College of Cardiology

Volumn 21, Issue 7, 1993, Pages 1638-1644

  Böcker, Dirk ^a   Block, Michael ^a   Isbruch, Frank ^a   Wietholt, Dietmar ^a   Hammel, Dieter ^a   Borggrefe, Martin ^a   Breithardt, Günter ^a  

^a Institute for Arteriosclerosis Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DEFIBRILLATION; FEMALE; HEART VENTRICLE FIBRILLATION; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HEART ARREST; HUMAN; MALE; MIDDLE AGE; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR;

EID: 0027173768     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(93)90380-J     Document Type: Article

References (23)

1. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings
2. Clinical evaluation of the internal automatic cardioverter-defibrillator in survivors of sudden cardiac death
3. Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease
4. Long-term outcome with the automatic implantable cardioverter-defibrillator
5. The automatic implantable cardioverter defibrillator as antiarrhythmic treatment modality of choice for survivors of cardiac arrest unrelated to acute myocardial infarction
6. Guidelines for the use of implantable cardioverter defibrillators
7. ACC/AHA Task Force report; guidelines for implantation of cardiac pacemakers and antiarrhythmic devices
8. Implantable cardioverter defibrillators in American Society of Pacing and Electrophysiology
9. Benefits of implantable defibrillators are overestimated by sudden death rates and better represented by total arrhythmic death rate
10. Significance of ventricular function in implantable defibrillator patients: Montefiore Hospital and Cleveland Clinic experience (abstr)
11. AICD benefit (editorial)
12. Classification of tachycardias causing ICD-therapies by cycle length memories (abstr)
13. Exacerbation of ventricular arrhythmias during the postoperative period after implantation of an automatic defibrillator
14. The automatic implantable cardioverter-defibrillator: the U.S. experience
15. Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias
16. The automatic implantable cardioverter-defibrillator: long-term clinical experience and outcome at a hospital without an open-heart surgery program
17. Influence of left ventricular function on outcome of patients treated with implantable defibrillators
18. Future studies with the implantable cardioverter defibrillator
19. Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias
20. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial
21. Effect of antiarrhythmic drug therapy on the incidence of shocks in patients who receive an implantable cardioverter defibrillator after a single episode of sustanted ventricular tachycardia/fibrillation
22. Clinical experience with a tiered-therapy, multiprogrammable antiarrhythmia device
23. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacer-, cardioverter, -defibrillator: results of a European multicenter study incorporating 102 implants